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Abstract
Introduction
There is increasing recognition of dry eye disease (DED) as a significant factor influencing
quality of life in seemingly normal individuals. Our goal was to determine the distribution of
Ocular Surface Disease Index (OSDI) scores in non-clinical individuals in Karachi, Pakistan.
Methods
We distributed OSDI questionnaires to subjects aged > 18 years with no active ocular complaint.
Examiners were selected from various areas of the city to administer questionnaires to
students and the general population. The OSDI score was grouped as per the following: normal
(0-12 points), mild (13-22 points), moderate (23-32 points), and severe (33-100 points).
Results
We surveyed 2433 individuals with a mean age of 30.7±15.6 years. Additionally, the mean OSDI
score was 22.4±18.7. To estimate prevalence, we used two OSDI score cutoffs: >13 (64.4%) and
>22 points (43.6%). Statistical significance was found using multivariate regression in the
following variables: age (p<0.001), contact lens wear (p<0.001), ocular allergies (p<0.001),
hypertension (p<0.001), diabetes (p=0.003), and smoking (p=0.047). When graphing mean age
against OSDI score, there was a large jump between the third and fourth decades; thereafter,
there was a steady increase. Similarly, when plotting smoking, the score was steady until five
years and then there was a sharp incline.
Conclusion
There was a high prevalence of DED in the studied population. Additionally, many systemic and
ocular factors were associated with this disease.
Categories: Ophthalmology, Public Health
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Introduction
The International Dry Eye Workshop (DEWS) II has defined dry eye disease (DED) as a
multifactorial disease affecting both the ocular surface and the tear film in which increased tear
film hyperosmolarity, ocular surface inflammation, and neurosensory problems can play a
causative role [1]. The prevalence has varied throughout the world. It has ranged from 7% in the
USA to 33% in Japan and Taiwan [2]. Additionally, a multitude of risk factors has been
identified such as age, smoking, and contact lens wear.
Several tools have been created to screen for this disease effectively and efficiently. These
include the Ocular Surface Disease Index (OSDI), Impact of Dry Eye on Everyday life (IDEEL) [3],
and the Standardized Patient Evaluation of Eye Dryness (SPEED) [4] questionnaires. Of these,
OSDI is a validated and quick method of evaluating DED, which makes it ideal for testing a
large population [5].
To our knowledge, no study has observed the prevalence of DED and observed its trends in a
large population in Pakistan. This is precisely the primary goal of this study. The secondary
goals are to observe the association of the OSDI score with a variety of demographic factors.
Materials And Methods
This was a cross-sectional study conducted in the city of Karachi, Pakistan, to assess the
symptoms of dry eyes using the OSDI (Allergen Inc, Irvine, Calif, USA). Additionally, we also
assessed risk factors like contact lens use, smoking, surgery, and alcohol use. The Ethics
Committee of Hashmanis Hospital approved this study according to the tenets of the
Declaration of Helsinki. Informed consent was obtained from each participant.
Samples and questionnaire
Examiners were selected from various areas of the city to administer questionnaires to other
students and the general population using convenience sampling. Subjects over the age of 18
years were included in the study. This study was conducted in residents with no active ocular
problems. We excluded patients with evidence of ocular surface disease and known
autoimmune conditions.
The questionnaire was divided into two parts. The first part asked about history including
smoking history or contact lens use. Additionally, it inquired about their comorbidities like
hypertension and diabetes. The second part was the OSDI questionnaire where subjects were
asked to describe their symptoms over the previous week. The questionnaire was administered
as a guided interview in two languages, English and Urdu.
The OSDI questionnaire assesses 12 items that evaluate both the symptoms of dry eye and its
effect on the vision. There are three sections that evaluate visual complaints, symptoms, and
any environmental triggers. The respondent is asked to list his complaints ranging from 0-4; 0
being “none of the time” and 4 equating to “all of the time.” The total score was calculated via
the following formula: OSDI = ([Sum of all question scores*100]/[Number of questions
answered*4)] [6].
The OSDI score was grouped as per the following: normal (0-12 points), mild (13-22 points),
moderate (23-32 points), and severe (33-100 points) [7]. Grouping for the number of years
smoking was done in the following way: < 1 year, 1-5 years, 6-10 years, 11-15 years, 16-20
years, and 20+ years.
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Sample size
We used the openepi calculator (openepi.com) to determine the sample size. We used an
estimated frequency of 33% [2], a confidence interval of 99%, and a design effect 1.0. The
minimum sample size came out to be 587.
Statistical analysis
All statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS
v23; IBM Corp., Armonk, NY). Descriptive statistics were used for calculating mean and
standard deviations. Prevalence was determined with four different methods: an OSDI of >13
and >22 and those with and without ocular factors. A Pearson correlation test, independent t-
test, and multivariate regression were used for the various variables. Graphs were created using




We surveyed 2433 individuals with a mean age of 30.7±15.6 years. Additionally, the mean OSDI
score was 22.4±18.7. The rest of the data can be seen in Table 1. The prevalence of dry eye with
this data set came out to be 64.4% (cut-off 13), and 43.6% (cut-off 22).




OSDI score** 22.4±18.7 17.9±16.1
TABLE 1: General characteristics
*Excluded patients with a history of ocular surgery, contact lens use, and ocular allergies, **OSDI=Ocular Surface Disease Index
We then repeated this analysis with the exclusion of patients with the following: a history of
ocular surgery (n=139), contact lens use (n=601), and ocular allergies (n=391). The prevalence
using this data came out to be 55.3% (> 13), and 33.9% (> 22). The distribution of the OSDI score
can be seen in Figure 1.
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FIGURE 1: Distribution of OSDI scores
*Excluded patients with history of ocular surgery, contact lens use, and ocular allergies
OSDI=Ocular Surface Disease Index
Variables
Statistical significance was found in the following variables: age (p<0.001), contact lens wear
(p<0.001), ocular allergies (p<0.001), hypertension (p<0.001), diabetes (p=0.003), and smoking
(p=0.047). The rest of the data can be seen in Table 2.
Variable Number Mean SD  Monovariate P-Value Multivariate P-Value
Age 2433 30.7 15.6 <0.001 <0.001
Gender    0.079 0.528
Male 813 23.4 18.9   
Female 1620 22.0 18.6   
Male > 45 years 134 34.5 17.3  0.321
Female > 45 years 246 37.8 17.4   
Contact lens 587   <0.001 <0.001
Yes  25.5 19.8   
No  21.5 18.3   
Smoking 329   <0.001 0.047
Yes  28.1 20.0   
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No  21.6 18.4   
Steroid use 123   <0.001 0.304
Yes  35.3 20.2   
No  21.8 18.4   
Alcohol 76   0.021 0.633
Yes  28.8 22.7   
No  22.2 18.6   
Systemic allergies 446   <0.001 0.255
Yes  28.3 20.6   
No  21.1 18.0   
Ocular allergies 390   <0.001 <0.001
Yes  36.3 20.0   
No  19.8 17.3   
Ocular surgery 120   <0.001 0.189
Yes  32.4 19.9   
No  22.0 18.5   
Hypertension 383   <0.001 <0.001
Yes  35.7 18.7   
No  20.0 17.6   
Diabetes 139   <0.001 0.003
Yes  36.6 16.7   
No  21.6 18.4   
TABLE 2: Effect of various variables on the OSDI score
*SD=standard deviation, OSDI=Ocular Surface Disease Index
The effect of age on the mean OSDI score has been plotted in Figure 2. The greatest jump comes
between the third and fourth decades and then there was a steady increase. Figure 3 shows the
mean OSDI score plotted against the number of smoking years (p<0.001). The score remains
steady until up to five years of smoking and then sees a sharp increase.
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FIGURE 2: The effect of age on the OSDI score
OSDI=Ocular Surface Disease Index
FIGURE 3: Influence of length of smoking on the OSDI score
OSDI=Ocular Surface Disease Index
Discussion
We performed a cross-sectional analysis using the OSDI questionnaire to understand the
distribution of dry eye symptoms across a non-clinical population. Additionally, we observed
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the associations and trends of several factors that could possibly influence this disease.
There is a large variation in the prevalence of DED across the world. Studies in India [8], Jordan
[9], France [10], and Iran [11] utilized the OSDI with a cut-off score of 20-22 points to calculate
prevalence. They reported 32%, 59%, 39.2%, and 18.3%, respectively. Singapore used the
McMonnies questionnaire to report a prevalence of 12.3% [12]. Numerous other studies have
reported their own data with custom questionnaires and clinical signs; we are not discussing
their prevalence as these are not directly comparable. Additionally, it is important to note that
the first three studies used a high cut-off of 22 points to maximize sensitivity [13].
Therefore, we have reported values with a minimum value of 13 (mild) and 22 (moderate), as
the true prevalence likely lies between these estimates. Furthermore, we subdivided our
population further into those without ophthalmic factors affecting the ocular surface and those
with. Therefore, we have reported a total of four prevalence values. The true prevalence lies
between 33.9%-64.4%, depending on the criteria employed.
Many studies have linked the female gender as a risk factor for DED [10-12]. One study in
Jordan shows no effect of gender at a younger age [9]. However, above 45 years of age, females
seemed to have a higher OSDI score. Androgens regulate the secretory activity of the lacrimal
gland [14] and their levels correlate with the signs and symptoms of DED [15]. Therefore, it was
theorized that due to the lower baseline of androgens in females, the minimum required levels
for the optimal functioning of the gland is reached quicker in aging women [16]. Additionally,
estrogen has been shown to stimulate meibomian gland activity, which exacerbates this
problem in post-menopausal women [14]. Interestingly, our study shows no statistically
significant gender predilection even when corrected for age or when analyzing only those over
the age of 45 years.
Age has also been shown to be a risk factor; our study agrees with this finding. There are a
range of etiologic factors that have been postulated; for example, a higher incidence of
comorbidities like diabetes, lowered corneal sensitivity [17], dysfunction of the lacrimal gland
[18], loss of functional goblet cells [19], or the inflammatory damage of lacrimal glands [16].
Interestingly, when we graphed out the means according to the age group, we found a stark
increase in the OSDI score, going from the third to fourth decades of life; thereafter, there was a
steady increase.
Smoking has been a controversial risk factor for the development of DED. A few studies show
an effect of smoking on the OSDI [20-21] while others disagree with this assessment [9,12]. Our
study showed statistical significance while controlling for other factors. Additionally, in Figure
3, we show that for up to five years of smoking, there seems to be no effect; thereafter, a sharp
increase is seen. It must be noted, however, that the baseline OSDI in smokers was higher even
in those that had smoked for < one year. Therefore, it seems that there may be early effects of
smoking on the ocular surface as well.
We found a significant difference in those suffering from diabetes and hypertension. Previous
studies agree with this result [22-23]. It is argued that hypertension is not a direct risk factor for
DED, however, antihypertensive medications contribute to the problem [22]. Encouragingly, not
all drugs of hypertension have been linked to DED; some drugs like the angiotensin-converting
enzyme inhibitor and receptor blockers have shown to improve the ocular surface [24]. Further
research is required to understand these relationships.
There are several limitations to this study. Firstly, we did not correlate symptoms with objective
signs on clinical tests. However, there are reports showing a weak association between the two;
this is an area requiring further study [25]. Secondly, the Urdu version of the questionnaire was
2020 Hashmani et al. Cureus 12(7): e9193. DOI 10.7759/cureus.9193 7 of 9
not validated. Lastly, a system of convenience sampling was employed.
Conclusions
There is a high prevalence of DED in the population residing in Karachi, Pakistan. The exact
number is hard to estimate due to various parameters that can be used. When attempting to
maximize sensitivity, like other studies, we demonstrate a larger prevalence in this population
when compared to others. Additionally, we demonstrate a range of factors like age, contact lens
wear, ocular allergies, hypertension, and diabetes that can influence DED.
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